Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Antibiotic Resistance and New Antimicrobial drugs

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1616646

LysR-type transcriptional regulator CARR represses the expression of bla CAR-2 and reduces P. diazotrophicus resistance to cefalothin, cefuroxime and cefotaxime

Provisionally accepted
  • 1Quanzhou Women's and Children's Hospital, Quanzhou, China
  • 2The Affiliated Women’s and Children’s Hospital of Huaqiao University, Quanzhou, China

The final, formatted version of the article will be published soon.

Background: P. diazotrophicus was isolated from a newborn with D-galactosemia complicated sepsis. A homologous bla CAR-2 gene, encoding CAR-2, a predicted member of the CAR family subclass B3 metallo-β-lactamases (MBLs), was found in the genome of this strain. This study aimed to explore the identification of a novel CAR-2 protein encoded by the chromosome of P. diazotrophicus Pd1 that exhibits the zinc-binding motifs of subclass B3 enzymes and the regulatory pattern of CARR , located directly upstream of the bla CAR-2 gene, on the bla CAR-2 gene and its impact on antibiotic resistance.Methods: Antibiotic susceptibility testing was conducted by the plate agar dilution method.Site-directed mutagenesis was conducted using Mut Express II Fast Mutagenesis Kit V2. Kinetic assays were used to determine the hydrolysis of β-Lactam.The construction of bacterial knockout strains was carried out according to the principle of homologous recombination.The detection of the mRNA expression level of the gene was performed by Real-time Quantitative PCR (qPCR).The minimum inhibitory concentrations (MICs) for E.coli DH5α(pHSG398::CAR-2), which expressed bla CAR-2, increased significantly for cefalothin, cefuroxime and cefotaxime sodium by 2-, 16-and 32-fold, respectively, which showed that bla CAR-2 had resistance to these three antibiotics. This protein, which was a MBL, contains two classical zinc-binding sites characteristic of subclass B3, with the amino acid motif His136, His138, His211, Asp140, His141, and His276.Among the six residues, His136, Asp140, and His211 exhibited the highest catalytic activity. We determined that CAR-2 can effectively hydrolyze cefalothin, cefuroxime and cefotaxime. The chloramphenicol resistance of the constructed E. coli DH5α strain was significantly reduced in the presence of CARR than in the absence of CARR.Compared with those for the wild-type P. diazotrophicus, MICs of cefalothin, cefuroxime and cefotaxime for the ΔCARR strain increased by 8-, 8-and 16-fold, respectively, and the expression level of bla CAR-2 also increased by approximately 10-fold.Overall, CAR-2 is a novel subclass B3 MBL of the CAR family that exhibits catalytic activity against cefalothin, cefuroxime and cefotaxime. CARR represses the expression of bla CAR-2 , thereby reducing the resistance of P.diazotrophicus to these antibiotics. This provided a theoretical basis for revealing new mechanisms of pathogen resistance.

Keywords: P. diazotrophicus, LysR-type transcriptional regulator CARR, Metallo-β-lactamases (MBLs), bla CAR-2, antibiotic resistance

Received: 23 Apr 2025; Accepted: 11 Aug 2025.

Copyright: © 2025 Lin, Lin and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Jiansheng Lin, Quanzhou Women's and Children's Hospital, Quanzhou, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.